HSP90B1 and neoplasm: A more recent study showed that the purine scaffold small molecule DN401 simultaneously inhibited all HSP90 paralogs, including HSP90, TRAP1, and GRP94, and synergized the anti-tumor effects with another TRAP1 inhibitor, gamitrnib (107).